Pharmaceutical Cleanroom News

Get the latest pharmaceutical cleanroom news and updates below. Cleanroom Connect brings you the latest news from around the world, featuring current topics and news in the Pharmaceutical and Biotech industries.

Vertex Pharmaceuticals Acquires CTP-656 from Concert Pharmaceuticals for the Treatment of Cystic Fibrosis

Vertex Pharmaceuticals Acquires CTP-656 from Concert Pharmaceuticals for the Treatment of Cystic Fibrosis

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it has signed a definitive asset purchase agreement to acquire CTP-656 from Concert Pharmaceuticals (Nasdaq: CNCE). CTP-656 is an investigational cystic fibrosis transmembrane conductance regulator (CFTR) potentiator that has the potential to be used as part of future once-daily combination regimens of CFTR modulators that treat the underlying cause of cystic fibrosis (CF). As part of the agreement, Vertex will pay Concert $160 million in cash for all worldwide development and commercialization rights to CTP-656.

Cystic Fibrosis Therapy Improved by Lipid-Based Nanoparticles

Cystic Fibrosis Therapy Improved by Lipid-Based Nanoparticles

Researchers at Oregon State University and Oregon Health & Science University are working on a treatment that holds great promise for improving the lives of cystic fibrosis patients. Cystic fibrosis is a progressive genetic disorder that results in persistent lung infection and afflicts 30,000 people in the U.S., with about 1,000 new cases diagnosed every year.

HPAPI Facility launches for production of the highest class of HPAPI

HPAPI Facility launches for production of the highest class of HPAPI

Minakem’s HPAPI production will be carried out with an Occupational Exposure Limit (OEL) below 0,1μg/m3/8h. This emphasis on Environment, Health and Safety (EHS) reflects Minakem’s more than 20 years’ experience in continuously monitoring and controlling hazardous working environments, marking its leadership in this area.

New State-of-the-Art Plasma Manufacturing Facility

New State-of-the-Art Plasma Manufacturing Facility

Shire plc, the global biotechnology leader in rare diseases, announced today that the United States Food and Drug Administration (FDA) has approved the company’s first submission for its new plasma manufacturing facility near Covington, Georgia for the production of GAMMAGARD LIQUID® [Immune Globulin Infusion (Human)] 10% Solution, a replacement therapy for primary humoral immunodeficiency (PI).

Merck KGaA Expands Chinese Business

Merck KGaA Expands Chinese Business

Merck KGaA, Darmstadt, Germany today announced today announced moves designed to pave the way for an even more successful future in China. Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced today announced moves designed to pave the way for an even more successful future in China.

Novacap Expands Pharmaceutical Offering with Acquisition of PCI Synthesis

Novacap Expands Pharmaceutical Offering with Acquisition of PCI Synthesis

Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an agreement to acquire Boston-based PCI Synthesis, a leading U.S. pharmaceutical contract development and manufacturing organization (CDMO), further reinforcing Novacap’s capabilities and offering for the pharmaceutical industry.

Probiotic bacteria can diagnose, prevent, and treat infections

Probiotic bacteria can diagnose, prevent, and treat infections

MIT engineers have developed a probiotic mix of natural and engineered a probiotic bacteria to diagnose and treat cholera, an intestinal infection that causes severe dehydration. Cholera outbreaks are usually caused by contaminated drinking water, and infections can turn fatal if not treated.

Chimeric Antigen Receptor T-Cell Therapy Improvements

Chimeric Antigen Receptor T-Cell Therapy Improvements

Cellectis, a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), today announced the publication of a study in Scientific Reports, a Nature Publishing Group journal, describing the development of the CubiCAR, an all-in-one Chime

E06 Antibody Blocks Inflammation

E06 Antibody Blocks Inflammation

E06 Antibody Blocks Inflammation, Protects Mice from Hardened Arteries and Liver Disease. Study uncovers new potential therapeutic approach for a number of diseases linked to inflammation, including atherosclerosis, aortic stenosis and hepatic steatosis

Pharmaceutical News

Pharmaceutical Cleanroom News and Advancements

The Pharmaceutical Cleanroom Industry or medicine industry is the commercial industry that discovers, develops, produces, and markets drugs or pharmaceuticals for various uses and formations of medicines and medications. The pharmaceutical cleanroom industry produces the controlled aseptic cleanroom environments where by the pharmaceutical products are created and packaged. Pharmaceutical companies create a various array of products for different applications.

The primary developments of Pharmaceutical companies are generic medications, branded pharmaceuticals and medical devices. The pharmaceutical companies are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs. Cleanroom Connect provides the latest Pharmaceutical Cleanroom News from various pharmaceutical and biopharma industries. Subscribe today to receive pharmaceutical and biopharmaceutical news and updates directly to your mailbox.

Pharmaceuctical Cleanroom News  |  Biotechnology Industry News  |  Medical Device News

The Pharmaceutical Cleanroom Industry is a booming industry, and production has been growing exponentially over the past few decades as innovations in the medical field have taken off. This increasing production has also led to increasing demands for safety features installed in industrial pharmaceutical manufacturing plants and storage areas. These safety procedures ensure the health of employees as well as the safe preservation of products that are stored for later use by consumers.